March 2, 2017 | Jewish Business News
The medical cannabis products include rectal and vaginal suppositories, transdermal pain relief patches and treatment of pain, burns and psoriasis.
Israeli pharmaceutical company Panaxia Pharmaceuticals Industries Ltd, specializing in medical cannabis R&D and manufacturing, and Ultra Health, New Mexico’s No. 1 cannabis company with a nationwide presence, launched their first medical cannabis production facility in the United States.
Based in Bernalillo, New Mexico, the facility will manufacture smokeless, accurately dosed cannabis medicine in a variety of delivery methods.
Although Panaxia pharmaceutical Industries produces more than 300 different conventional medication products, the company has been developing and manufacturing medical products based on cannabis since 2010.
Panaxia is providing smokeless proprietary cannabinoid dosage and treatment protocols, which are not readily available in the United States, in order to manufacture state-of-the-art products to treat a number of illnesses. The production facility is implementing Panaxia’s technology.
Read More On: Jewish Business News Website